In summary, these results indicate that the genomic changes here identified might be insufficient to induce SS cell proliferation and emphasize the role of factors present within the skin like cytokines [55], antigens able to engage T-Cell Receptor [56] and the SDF-1 and CCL21 chemokines here studied. This evidence concerns the gene CCL21 and synovial sarcoma.